Sandi Coleman
Hospitalist · Miami, FLNPI 1619169497
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, AstraZeneca. That places this record below the midpoint for hospitalist clinicians in FL, where the typical reported total is $187.
Across 1 payment — averaging $30.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$30
Across 2 payments — averaging $1,321,773 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$2.6M
What the payments were for
- Food & beverage$30100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 1 | $30 |
How this compares
$30 in reported general payments places this provider in the 20th percentile of 1,570 hospitalist providers in Florida.
Other hospitalist in Miami
- Murray EpsteinMiami$370K
- Francisco Perez LoretoMiami$17K
- Alexangel SantanaMiami$7K
- Yasser AsmarMiami$7K
- Seth BleicherMiami$6K
- Daniel LopezMiami$4K
- Tina SanjarMiami$3K
- Oliver AbelaFort Myers$77K
- Joshua LenchusFort Lauderdale$73K
- Tuncay TaskesenThe Villages$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.